{"text": "TITLE:\n      Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment\nSUMMARY:\n      Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension,\n      who do not tolerate ACE inhibitoR treatment\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  Patients over 18 years of age\n          -  Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)\n          -  Patients, who do not tolerate ACE inhibitors (must be documented in the official\n             ambulant documentation)\n        Inclusion criteria for the control arm (treated by ACEi):\n          -  Patients over 18 years of age\n          -  Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)\n          -  Patients, who tolerate ACEi treatment\n        Exclusion Criteria:\n          -  Cholestasis, severe hepatic insufficiency\n          -  Allergy to telmisartan\n          -  Gravidity or lactation\n        Exclusion criteria for the arm of patient treated by ACEi:\n          -  Cholestasis, severe hepatic insufficiency\n          -  Allergy to ACEi\n          -  Gravidity or lactation\n", "cuis": "C0733511 C1550191 C0020538 C1963138 C3248638 C0947663 C0085580 C0455405 C1696708 C3829824 C0087111 C1533734 C3887704 C0746919 C0003842 C1174786 C0013227 C1254351 C0003015 C1552616 C1706244 C0020538 C0264648 C0020649 C0733511 C1550191 C1174786 C0013227 C1254351 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0003015 C0243161 C0013893 C0243161 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0020538 C1963138 C1696708 C2748577 C0947663 C0003842 C1306620 C1305849 C0003015 C1301725 C1609436 C1301746 C1547673 C1563337 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0175636 C0920316 C4035885 C0243161 C0446516 C1140618 C0332155 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0020538 C1963138 C1696708 C2748577 C0947663 C0003842 C1306620 C1305849 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0243161 C1306571 C0008370 C1306232 C0248719 C0020517 C0718579 C1527304 C3539909 C0549206 C0600457 C0020610 C0243161 C0446516 C1140618 C0332155 C1306571 C0008370 C1306232 C0020517 C0718579 C1527304 C3539909 C0549206 C0600457 C0020610 ", "concepts": "Surveillance, CDC Surveillance, Hypertension NOS, Hypertension, Hypertension mg, Hypertensin, Hypertension NOS, FH: Hypertension, Pre-Hypertension, Has Hypertension, treatment, Treatment, treatment, No Treatment, Arterial, pritor, Drug, Drug, ACE inhibitor summary, summary arterial hypertension, Renal arterial hypertension, arterial hypotension, Surveillance, CDC Surveillance, pritor, drug, drug Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, ACE inhibitor criteria, Eligibility Criteria Patient, Patient, Patient, Patient, Patient, Patient hypertension, Hypertension, Prehypertensions, No hypertension, hypertensin, Arterial, sbp, dbp ACE inhibitors, Documented, Documented, document, document, document, Patient, Patient, Patient, Patient, Patient, Patient Documentation, documentations, Ambulant criteria, arm, arm, untreated Patient, Patient, Patient, Patient, Patient, Patient hypertension, Hypertension, Prehypertensions, No hypertension, hypertensin, Arterial, sbp, dbp Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, Patient, Patient, Patient, Patient, Patient, Patient Criteria hepatic insufficiency, Cholestasis, severed telmisartan, Allergy., Allergy, Allergy, Allergy Gravidity, Gravidity, Poor lactation criteria, arm, arm, untreated hepatic insufficiency, Cholestasis, severed Allergy., Allergy, Allergy, Allergy Gravidity, Gravidity, Poor lactation "}
